EnWave presenta los resultados financieros consolidados provisionales del primer trimestre de 2024

Delta, BC, February 23, 2024

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the first quarter ended December 31, 2023.  

All values in thousands and denoted in CAD unless otherwise stated.

• Reported royalty revenues of $480, representing an increase of $67 relative to the comparable period in the prior year. Royalties grew due to increased partner product sales and production offset by a decrease in exclusivity fees for the quarter.
• Reported an overall decrease in Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $303 for Q1 2024 relative to the comparable period in the prior year, with the decrease primarily related to a reduction in commissions to third party sales representatives and concerted efforts to maintain discretionary spending.
• Reported revenue for Q1 2023 of $1,262, representing a decrease of $1,523 relative to the comparable period in the prior year.   The decrease was primarily related to fewer machine sales and machines in fabrication due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV™”) machine orders.
• Gross margin for the three months ended Q1 2024 was 18% compared to 37% for the three months ended Q1 2023. The decrease in margin was a result of fewer machine sales and machines in fabrication to absorb fixed overhead costs.
• Reported an Adjusted EBITDA⁽¹⁾ loss of $756 for Q1 2024, a decrease of $500 from the comparable period in the prior year.

Consolidated Financial Performance:

• Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a

reconciliation to the nearest IFRS equivalent.

EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net

Significant Corporate Accomplishments in Q1 2024 and Subsequently:

• Signed a Technology Evaluation and License Option Agreement with a North American multi-state cannabis company to evaluate REV™ Technology over other incumbent drying methods.  
• Signed a toll manufacturing agreement with BranchOut Food Inc. to produce vegetable snack products on an interim basis at the Company’s REVworx facility in Delta, Canada.

Medidas financieras distintas de las NIIF:

This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.

Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.

Acerca de EnWave  

EnWave es líder mundial en innovación y aplicación de la deshidratación por microondas al vacío. Desde su sede en Delta (Columbia Británica), EnWave ha desarrollado una sólida cartera de propiedad intelectual, ha perfeccionado su tecnología Radiant Energy Vacuum (REV™) y ha transformado una idea innovadora en una solución de secado probada, consistente y escalable para las industrias alimentaria, farmacéutica y del cannabis que supera ampliamente a los métodos de secado tradicionales en eficiencia, capacidad, calidad del producto y coste.

Con más de cincuenta socios generadores de royalties repartidos por veintiséis países y cinco continentes, los socios licenciatarios de EnWave están creando aperitivos e ingredientes rentables y nunca vistos, mejorando la calidad y consistencia de sus ofertas existentes, funcionando de forma más ágil y llegando al mercado más rápidamente con la tecnología patentada de la empresa, la maquinaria bajo licencia y la orientación de expertos.

La estrategia de EnWave consiste en firmar licencias comerciales sujetas a derechos de autor con productores de alimentos que deseen secar mejor, más rápido y de forma más económica que la liofilización, el secado en bastidor y el secado al aire, y disfrutar de las siguientes ventajas: producir productos nuevos e interesantes, alcanzar niveles óptimos de humedad hasta siete veces más rápido y mejorar el sabor, la textura, el color y el valor nutritivo del producto.

Más información en EnWave.net. 

Corporación EnWave 

Sr. Brent Charleton, CFA 

Presidente y Consejero Delegado 

Para más información: 

Brent Charleton, CFA, Presidente y Director General, +1 (778) 378-9616
Correo electrónico: bcharleton@enwave.net  

Dylan Murray, Director Financiero, +1 (778) 870-0729
Correo electrónico: dmurray@enwave.net   

Ni la TSX Venture Exchange ni su Proveedor de Servicios de Regulación (según se define este término en las políticas de la TSX Venture Exchange) aceptan responsabilidad alguna por la adecuación o exactitud de este comunicado.